seed
Stage
1
Investors
About
Creasallis develops CreaTap, a patented antibody engineering technology that enhances penetration of antibody-based therapeutics into solid tumors to improve efficacy in cancer treatment.
Explore Creasallis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.